Faculty profile
Alexandre Gagnon
Back to facultyResearch
Read how they describe their research on their Université du Québec à Montréal profile.
Latest funding
- $78,000
Organobismuth chemistry: from a priori predictions to unexplored territories.
NSERC · 2023 · Principal investigator
- $30,000
Development of a Selective Bromodomain Inhibitor Involved in the SWI/SNF Chromatin Remodeling Complex
NSERC · 2019 · Principal investigator
- $25,000
Synthesis of Small-Molecule Inhibitors Targeting Bromodomain Containing Proteins
NSERC · 2018 · Principal investigator
No publications available.
Organobismuth chemistry: from a priori predictions to unexplored territories.
Principal investigators: Gagnon, Alexandre
Keywords: organobismuth compounds; metal catalysis; trivalent bismuth compounds; pentavalent bismuth compounds; alkylbismuth compounds; cycloalkybismuth compounds; cyclopropylation reactions; alkenylation reactions; alkynylation reactions; low-valent bismuth compounds
Development of a Selective Bromodomain Inhibitor Involved in the SWI/SNF Chromatin Remodeling Complex
Principal investigators: Gagnon, Alexandre
Synthesis of Small-Molecule Inhibitors Targeting Bromodomain Containing Proteins
Principal investigators: Gagnon, Alexandre
Expanding the Scope of Organobismuth Compounds in Organic Synthesis
Principal investigators: Gagnon, Alexandre
Operations and Maintenance Support: Montréal Centre for Structural Analysis by X-Ray Diffraction
Principal investigators: Wuest, James
Preparation of a library of drug-like compounds through chemoselective arylation of a polyfunctional drug molecule
Principal investigators: Gagnon, Alexandre
NSERC CREATE Collaborative Medicinal Chemistry Network in Epigenetics Training (ChemNET):Training Canadian chemists within a global open access public-private partnership
Principal investigators: Edwards, Aled
Application of organobismuth chemistry in the design and development of drug libraries
Principal investigators: Gagnon, Alexandre
""Organobismuth reagents in C-N, C-O, and C-C bond forming reactions and synthesis of biologically active compounds.""
Principal investigators: Gagnon, Alexandre
Development of a medicinal chemistry route involving metal-catalyzed reactions for the synthesis of a small set of inhibitors of a selected biological target
Principal investigators: Gagnon, Alexandre
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.
Profile data last refreshed on September 26, 2026 from the university directory, publication records and CIHR, NSERC and SSHRC funding.